
Inato
AI-powered patient recruitment.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor | €0.0 | round |
investor investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
* | $20.0m | Series A | |
Total Funding | 000k |
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 44 % | (8 %) | 9 % | 28 % | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 3 % | 5 % | 2 % | 14 % | 12 % | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 2 % | (170 %) | (302 %) | (593 %) | (2329 %) | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Inato operates a marketplace designed to make clinical trials more appealing and accessible to doctors. The platform matches physicians with the most suitable studies and simplifies the research process, allowing doctors to focus more on patient care. Inato serves healthcare professionals and clinical trial sponsors, operating within the healthcare and pharmaceutical markets. The business model revolves around facilitating connections between doctors and clinical trials, thereby improving trial efficiency and outcomes. Revenue is generated through fees from trial sponsors who benefit from increased participation and streamlined processes.
Keywords: clinical trials, marketplace, doctors, research, patient care, healthcare, pharmaceutical, trial matching, efficiency, sponsors.